Phase 3 trial results show roflumilast cream 0.05% to be a safe and effective treatment for children with atopic dermatitis.

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.

An Australian-first study has found that certain natural fats which exist in the skin of babies, called lipids, are linked to the development of ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

Many TikTokers attest to its deeply hydrating and skin-improving ability — notably, former reality TV star Lo Bosworth, who ...

Dermatologists wax poetic about changing your skin care routine with the seasons. As we head into the warmer spring months, ...

A doctor has spoken out against a trend that has gone viral on TikTok, which involves people with eczema skipping moisturiser ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...

Poundland is selling the Elizabeth Arden Visible Difference Moisture Cream for a bargain price of £15 instead of £39 ...